Ignite Creation Date:
2025-12-25 @ 4:03 AM
Ignite Modification Date:
2026-01-29 @ 6:34 AM
Study NCT ID:
NCT03619902
Status:
COMPLETED
Last Update Posted:
2025-09-16
First Post:
2018-07-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Generalized Pustular Psoriasis
Sponsor:
Vanda Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-01-30
Start Date Type:
ACTUAL
Primary Completion Date:
2021-01-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-01-20
Completion Date Type:
ACTUAL
First Submit Date:
2018-07-19
First Submit QC Date:
None
Study First Post Date:
2018-08-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-03-02
Results First Submit QC Date:
None
Results First Post Date:
2022-03-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-02
Last Update Post Date:
2025-09-16
Last Update Post Date Type:
ESTIMATED